Term
| Penicillins: Mechanisms of Resistance |
|
Definition
- Beta Lactamase Producing
- Alteration of PBPs (MRSA)
- Modification of outer cell membrane (Most G-)
|
|
|
Term
| Penicillin G Route of Administration |
|
Definition
|
|
Term
| Penicillin VK Route of Administration |
|
Definition
|
|
Term
| Benzathine Penicillin G Route of Administration |
|
Definition
|
|
Term
| Procaine Penicillin G Route of Administration |
|
Definition
|
|
Term
| Oxacillin Route of Administration |
|
Definition
|
|
Term
| Nafcillin Route of Administration |
|
Definition
|
|
Term
| Dicloxacillin Route of Administration |
|
Definition
|
|
Term
| Ampicillin Route of Administration |
|
Definition
|
|
Term
| Amoxicillin Route of Administration |
|
Definition
|
|
Term
| Ticarcillin Route of Administration |
|
Definition
|
|
Term
| Piperacillin Route of Administration |
|
Definition
|
|
Term
| Why is Ticarcillin not used much in the hospital? |
|
Definition
| It is formulated with Na+ and is harmful to sick patients -- don't want to overload someone that has CHF with Na+ |
|
|
Term
| Amoxicillin/Clavulanic Acid Route of Administration |
|
Definition
|
|
Term
| Ampicillin/Sulbactam Route of Administration |
|
Definition
|
|
Term
| Ticarcillin/Clavulanic Acid Route of Administration |
|
Definition
|
|
Term
| Piperacillin/Tazobactam Route of Administration |
|
Definition
|
|
Term
| Which antibiotics out of the penicillin classes do not need to be renally dosed? |
|
Definition
- Nafcillin (primarily hepatic)
- Oxacillin (renal and hepatic)
|
|
|
Term
| Adverse Reactions of Penicillins |
|
Definition
|
Anaphylaxis (can't rechallenge with another beta lactam)
Urticaria (hives)
Drug Fever
- GI (N/V/D - occurs with PO classes)
- Hematologic
- Neurologic (seizures)
|
|
|
Term
| Cephalosporins: Mechanism of Resistance |
|
Definition
- Beta Lactamases
- Alteration of PBPs
- Outer cell membranes changes
|
|
|
Term
| Cefazolin Route of Administration |
|
Definition
|
|
Term
| Cephalexin Route of Administration |
|
Definition
|
|
Term
| Cefuroxime Route of Administration |
|
Definition
|
|
Term
| Cefoxitin Route of Administration |
|
Definition
|
|
Term
| Cefotetan Route of Administration |
|
Definition
|
|
Term
| Ceftriaxone Route of Administration |
|
Definition
|
|
Term
| Cefotaxime Route of Administration |
|
Definition
|
|
Term
| Ceftazidime Route of Administration |
|
Definition
|
|
Term
| Cefepime Route of Administration |
|
Definition
|
|
Term
| Route of Elimination for Cephalosporins |
|
Definition
Renal
Exception:
Ceftriaxone (biliary)
Cefoperazone |
|
|
Term
| Adverse Reactions of Cephalosporins |
|
Definition
|
Anaphylaxis
Urticaria
Drug Fever
- Hematologic
- Neurologic
- Disulfiram-Like Reactions (MTT side chain only)
Cefotetan, cefamandole, cefmetazole, cefoperazone, moxalactam
Flushing, Vomiting - with concomitant alcohol consumption
Increased INR |
|
|
Term
| Carbapenems: Mechanism of Resistance |
|
Definition
- Decreased penetration (G- bacilli)
- Altered PBPs
- Production of broad spectrum Beta Lactamases
|
|
|
Term
| Carbapenems are excreted by which route? |
|
Definition
|
|
Term
| Imipenem Route of Administration |
|
Definition
|
|
Term
| Meropenem Route of Administration |
|
Definition
|
|
Term
| Ertapenem Route of Administration |
|
Definition
|
|
Term
| Doripenem Route of Administration |
|
Definition
|
|
Term
| Which Carbapenem is administered with Cilastatin? |
|
Definition
Imipenem
- It is susceptible to dehydropeptidase 1 of the renal brush border
- Cilastatin is a DHP 1 inhibitor
|
|
|
Term
| Adverse Reactions of Carbapenems |
|
Definition
|
high risk of C. difficile
Anaphylaxis, urticaria, drug fever
Cross reaction with penicillins is higher than cephalosporins
- Seizures (Imipenem > all other beta lactams, due to accumulation of cilastatin)
|
|
|
Term
| Aztreonam Route of Administration |
|
Definition
|
|
Term
| Aztreonam: Mechanism of Resistance |
|
Definition
| Extended Spectrum Beta Lactamases |
|
|
Term
| Adverse Reactions of Aztreonam |
|
Definition
Weakly Immunogenic (due to one ring)
People with PCN allergy can use aztreonam |
|
|
Term
|
Definition
- Binds irreversibly to 30S bacterial ribosomal subunit --> interference of genetic code and inhibition of protein synthesis
- Bactericidal
|
|
|
Term
| Aminoglycosides: Mechanism of Resistance |
|
Definition
- Ribosomal mutation --> drug cannot bind to 30S subunit
- Reduce transport into cell
- Plasmid-mediated aminoglycoside-modifying enzymes
|
|
|
Term
| Aminoglycosides route(s) of elimination |
|
Definition
|
|
Term
| Advantages of Once Daily Dosing of Aminoglycosides |
|
Definition
- Improves peak to MIC ratio and maximizes concentration dependent bactericidal activity
- Takes advantage of post-antibiotic effect
- Gives kidneys time to recover so possibly less nephrotoxicity
- Less potential for resistance
- Lower cost of supplies at nursing time
|
|
|
Term
| Aminoglycosides can be used in synergy to fight what types of infections? |
|
Definition
G+ Infections
MSSA
Enterococci |
|
|
Term
| Which aminoglycoside has the best Pseudomonas aeruginosa activity? |
|
Definition
|
|
Term
| Adverse Reactions of Aminoglycosides |
|
Definition
Aminoglycosides are Mean O'l Guys!
- Nephrotoxicity
- Ototoxicity (vestibular and auditory)
- Neuromuscular Blockade (if infused too quickly)
|
|
|
Term
|
Definition
- Structural analoge of p-aminobenzoic acid (PABA), the building block used by bacteria to make dihydrofolic acid
- Dihydrofolic acid is used to make folic acid, which is used for nucleotide synthesis
- Sulfamethoxazole competitively inhibits bacterial dihydropteroate synthetase, an enzyme critical for folic acid biosynthesis
|
|
|
Term
|
Definition
- Competitively inhibits dihydrofolate reductase, inhibiting conversion of dihydrofolic acid to tetrahydrofolic acid, the metabolically active cofactor for synthesis of purines, thymies, and DNA
|
|
|
Term
| TMP-Sulfamethoxazole is the DOC for what infections? |
|
Definition
|
|
Term
| TMP-Sulfamethoxazole is the only PO drug for: |
|
Definition
| Staphylcoccus aureus (including MRSA) infections |
|
|
Term
| Gentamicin Route of Administration |
|
Definition
|
|
Term
| Tobramycin Route of Administration |
|
Definition
|
|
Term
| Amikacin Route of Administration |
|
Definition
|
|
Term
| Streptomycin Route of Administration |
|
Definition
|
|
Term
| TMP-Sulfamethoxazole are eliminated by what routes? |
|
Definition
|
|
Term
| Adverse Reactions of TMP-Sulfamethoxazole |
|
Definition
- Hypersensitivity reactions
- Crystallization in the Kidneys - counsel patients to take with water
- Hematologic - bone marrow suppression at high doses
|
|
|
Term
|
Definition
- Binds reversibly to 30S bacterial ribosomal subunit
- Blocks attachment of tRNA to an acceptor site on the mRNA ribosomal complex
|
|
|
Term
| Doxycycline Route of Administration |
|
Definition
|
|
Term
| Indications of Tetracyclines |
|
Definition
- Respiratory Infections
- Genital Infections
- Skin Infections
|
|
|
Term
| Adverse Reactions of Tetracyclines |
|
Definition
- Photosensitivity
- Discoloration of Developing Teeth - CI < 8 yo, pregnant, nursing mothers
- Esophageal Ulceration
|
|
|
Term
|
Definition
- A glycylcycline antibiotic
- Similar MOA as tetracyclines (inhibits 30S ribosomal subunit)
- 5X binding affinity -- overcomes resistance mechanisms (ribosomal and efflux pumps)
|
|
|
Term
| Tigecycline: Spectrum of Activity |
|
Definition
- Staph. aureus (inclusing MRSA)
- Enterococcus (including VRE, excluding Proteus mirabilis)
- Strep. pneumoniae (including PRSP)
- Enterics (including ESBLs)
- Non-Enterics (excluding P. aeruginosa)
- Respiratory G-
- Anaerobes
- Atypicals
|
|
|
Term
| Adverse Effects of Tigecycline |
|
Definition
|
|
Term
| Tigecycline Route of Administration |
|
Definition
|
|
Term
| When should you decrease maintenance dose of Tigecycline? |
|
Definition
| Patients with liver failure |
|
|
Term
|
Definition
| Reversibly inhibits 50S ribosomal subunit |
|
|
Term
| Adverse Effects of Macrolides |
|
Definition
|
|
Term
| Erythromycin Drug Interactions |
|
Definition
| Hepatic Cytochrome P450 - inhibits CYP 3A4 |
|
|
Term
| Clarithromycin Drug Interactions |
|
Definition
| Hepatic Cytochrome P450 - inhibits CYP 3A4 |
|
|
Term
| Major Problem with Telithromycin |
|
Definition
|
|
Term
|
Definition
| Inhibits bacterial Topoisomerase II and IV |
|
|
Term
| Quinolones: Mechanism of Resistance |
|
Definition
- Point mutations
- Decrease outer membrane permeability
|
|
|
Term
| Ciprofloxacin Route of Administration |
|
Definition
|
|
Term
| Levofloxacin Route of Administration |
|
Definition
|
|
Term
| Moxifloxacin Route of Administration |
|
Definition
|
|
Term
Which of the following are used for systemic AND urinary tract infections?
- Moxifloxacin
- Levofloxacin
- Ciprofloxacin
- Gemifloxacin
|
|
Definition
Ciprofloxacin and Levofloxacin are used for bacteremia and UTIs
Moxifloxacin is NOT used for UTIs
Gemifloxacin is used for respiratory tract infections ONLY |
|
|
Term
| Adverse Effects of Quinolones |
|
Definition
- CNS effects (dizziness)
- Arthropathy
- Tendonitis/Tendon Rupture (Black Box Warning for kids - inhibits cartilage development)
- QT Interval Prolongation
|
|
|
Term
| What is a critical counseling point for a patient that is on a quinolone and is taking an iron supplement? |
|
Definition
- CI when taking both at same moment in time
- Separate Quinolone and Iron supplement
- Iron supplement 1 hr before Quinolone or 2 hours after Quinolone
- Some say 4 before or 4 after
|
|
|
Term
|
Definition
Lincosamide Antibiotic
Inhibits bacterial protein synthesis by binding to 50S ribosomal subunit |
|
|
Term
| Route of Elimination for Clindamycin |
|
Definition
Hepatically Metabolized
No dosage adjustment for renal impairment |
|
|
Term
| T/F: Clindamycin requires dosage adjustment in patients that are renally retarded |
|
Definition
False
Only patients that are hepatically retarded need dosage adjustments, b/c it is hepatically metabolized |
|
|
Term
| Adverse Effects of Tigecycline |
|
Definition
|
|
Term
|
Definition
- Enters cell by passive diffusion and is activated by reductive processes
- This produces short-lived metabolites that damage bacterial DNA and subsequently causes cell death
|
|
|
Term
| Metronidazole Route of Elimination |
|
Definition
- Hepatically metabolized
- No dosage adjustment unless severe kidney failure
|
|
|
Term
| Metronidazole Route of Administration |
|
Definition
|
|
Term
| Adverse Effects of Metronidazole |
|
Definition
- CNS effects
- GI upset
- Metallic taste
- Disulfiram-Like Reaction (possible but not likely - don't use with alcohol)
|
|
|
Term
|
Definition
- Binds reversibly to 50S bacterial ribosomal subunit
- Inhibits protein synthesis
|
|
|
Term
| Chloramphenicol Route of Elimination |
|
Definition
| Primarily metabolized in liver |
|
|
Term
| Adverse Effects of Chloramphenicol |
|
Definition
- Aplastic anemia (irreversible)
- Bone marrow suppression (reversible)
- Gray Baby Syndrome (primarily neonates)
|
|
|
Term
| Vancomycin Route of Administration |
|
Definition
|
|
Term
| Vancomycin Route of Elimination |
|
Definition
|
|
Term
| Adverse Effects of Vancomycin |
|
Definition
- Nephrotoxicity - not as bad as aminoglycosides
- Drug Fever
- Infusion-Related Side Effects
"Red Man" Syndrome
Hypotension
|
|
|
Term
| Quinupristin/Dalfopristin: MOA |
|
Definition
| Dalfprostin has been shown to inhibit the early phase of protein synthesis while Quinupristin inhibits the late phase of protein synthesis |
|
|
Term
| Quinupristin/Dalfopristin Route of Elimination |
|
Definition
- Metabolized to several active major metabolites
- Fecal excretion constitutes the main elimination route for both parent drugs and their metabolites
|
|
|
Term
| Quinupristin/Dalfopristin Spectrum of Activity |
|
Definition
- Enterococcus faecium (VRE), not E. faecalis
- Staph. aureus
- Strep. pyogenes
|
|
|
Term
| Adverse Effects of Quinupristin/Dalfopristin |
|
Definition
- Inflammation at infusion site
- Arthralgia/myalgia
|
|
|
Term
|
Definition
Oxazolidine Antibiotic
Binds to 23S rRNA of the 50S subunit --> prevents formation of a functional 70S initiation complex
-static against Staph.
-cidal against Strep. |
|
|
Term
| Linezolid Route of Elimination |
|
Definition
- Renal clearnace is low and suggests net tubular reabsorption
- Mainly Non-Renal
|
|
|
Term
| Linezolid Spectrum of Activity |
|
Definition
MRSA
VRE
Strep. pneumoniae |
|
|
Term
| Adverse Effects of Linezolid |
|
Definition
|
|
Term
| Linezolid Drug Interactions |
|
Definition
| MAOI - may lead serotonin syndrome |
|
|
Term
|
Definition
Cyclic Lipopeptide Antibiotic
- Inserts lipophilic tail into cytoplasmic membrane --> forms a channel that causes depolarization
- Efflux of K+ and perhaps other ions inhibits macromolecular synthesis and leads to cell death
- Kills bacteria but leaves cell wall intact which may potentially lead to toxins being suddenly released into the system
|
|
|
Term
| Daptomycin Spectrum of Activity |
|
Definition
|
|
Term
| Adverse Effects of Daptomycin |
|
Definition
Myopathy
Not a selective agent and can target cell membranes of skeletal muscles |
|
|
Term
| Daptomycin Route of Administration |
|
Definition
|
|
Term
| Telavancin Route of Administration |
|
Definition
|
|
Term
|
Definition
Lipoglycopeptide
- Combines mechanisms of both vancomycin (glycopeptide) and daptomycin (cyclic lipopeptide)
- Works on cell wall and cell membrane
- Bactericidal
|
|
|
Term
| Adverse Effects of Telavancin |
|
Definition
Nephrotoxicity
Black Box Warning: Birth Defects |
|
|
Term
| Telavancin Route of Elimination |
|
Definition
|
|
Term
| Chloramphenicol Route of Administration |
|
Definition
|
|
Term
| Azithromycin Route of Administration |
|
Definition
|
|
Term
| Quinupristin/Dalfopristin Route of Administration |
|
Definition
|
|
Term
| Linezolid Route of Administration |
|
Definition
|
|